-
1
-
-
49349083936
-
-
Chapter 18. Psoriasis. 8th ed. New York Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ Dallas NA, eds NY: McGraw-Hill
-
Gudjonsson JE, Elder JT. Chapter 18. Psoriasis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Dallas NA, eds. Fitzpatrick's dermatology in general medicine, 8th ed. New York, NY: McGraw-Hill, 2012.
-
(2012)
Fitzpatrick's Dermatology in General Medicine
-
-
Gudjonsson, J.E.1
Elder, J.T.2
-
2
-
-
84864968572
-
Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation
-
Bae YS, Van Voorhees AS, Hsu S, et al. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2012: 67 (3): 459-477.
-
(2012)
J Am Acad Dermatol
, vol.67
, Issue.3
, pp. 459-477
-
-
Bae, Y.S.1
Van Voorhees, A.S.2
Hsu, S.3
-
3
-
-
34250326394
-
Management of psoriasis in pregnancy
-
Weatherhead S, Robson SC, Reynolds NJ. Management of psoriasis in pregnancy. BMJ 2007: 334 (7605): 1218-1220.
-
(2007)
BMJ
, vol.334
, Issue.7605
, pp. 1218-1220
-
-
Weatherhead, S.1
Robson, S.C.2
Reynolds, N.J.3
-
4
-
-
18544389730
-
Hormonal effect on psoriasis in pregnancy and post partum
-
Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol 2005: 141 (5): 601-606.
-
(2005)
Arch Dermatol
, vol.141
, Issue.5
, pp. 601-606
-
-
Murase, J.E.1
Chan, K.K.2
Garite, T.J.3
Cooper, D.M.4
Weinstein, G.D.5
-
7
-
-
0038268815
-
Clinical course of psoriasis during pregnancy
-
Raychaudhuri SP, Navare T, Gross J, Raychaudhuri SK. Clinical course of psoriasis during pregnancy. Int J Dermatol 2003: 42 (7): 518-520.
-
(2003)
Int J Dermatol
, vol.42
, Issue.7
, pp. 518-520
-
-
Raychaudhuri, S.P.1
Navare, T.2
Gross, J.3
Raychaudhuri, S.K.4
-
8
-
-
0035927490
-
17-betaestradiol suppresses IL-2 and IL-2 receptor
-
McMurray RW, Ndebele K, Hardy KJ, Jenkins JK. 17-betaestradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001: 14 (6): 324-333.
-
(2001)
Cytokine
, vol.14
, Issue.6
, pp. 324-333
-
-
McMurray, R.W.1
Ndebele, K.2
Hardy, K.J.3
Jenkins, J.K.4
-
9
-
-
47049090309
-
Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases
-
Lam J, Polifka JE, Dohil MA. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J AmAcad Dermatol 2008: 59 (2): 295-315.
-
(2008)
J AmAcad Dermatol
, vol.59
, Issue.2
, pp. 295-315
-
-
Lam, J.1
Polifka, J.E.2
Dohil, M.A.3
-
10
-
-
0041823385
-
Case-control study of cleft lip or palate after maternal use of topical corticosteroids
-
Edwards MJ, Agho K, Attia J, et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids. Am J Med Genet 2003: 120A: 459-463.
-
(2003)
Am J Med Genet
, vol.120 A
, pp. 459-463
-
-
Edwards, M.J.1
Agho, K.2
Attia, J.3
-
11
-
-
36448987949
-
National BirthDefects Prevention Study.Maternal corticosteroid use and orofacial clefts
-
e1-7
-
Carmichael SL, Shaw GM,Ma C,Werler MM, Rasmussen SA, Lammer EJ;National BirthDefects Prevention Study.Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007: 197 (6): 585 e1-7.
-
(2007)
Am J Obstet Gynecol
, vol.197
, Issue.6
, pp. 585
-
-
Carmichael, S.L.1
Shaw, G.M.2
Ma, C.3
Werler, M.M.4
Rasmussen, S.A.5
Lammer, E.J.6
-
12
-
-
0036202487
-
Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy
-
Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand 2002: 81 (3): 234-239.
-
(2002)
Acta Obstet Gynecol Scand
, vol.81
, Issue.3
, pp. 234-239
-
-
Mygind, H.1
Thulstrup, A.M.2
Pedersen, L.3
Larsen, H.4
-
13
-
-
84856377466
-
Evidence-based (S3) guideline on topical corticosteroids in pregnancy
-
Chi CC, Kirtschig G, Aberer W, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol 2011: 165 (5): 943-952.
-
(2011)
Br J Dermatol
, vol.165
, Issue.5
, pp. 943-952
-
-
Chi, C.C.1
Kirtschig, G.2
Aberer, W.3
-
14
-
-
0032877642
-
A retrospective study of the teratogenicity of dermatological coal tar products
-
Franssen ME, van der Wilt GJ, de Jong PC, Bos RP, Arnold WP. A retrospective study of the teratogenicity of dermatological coal tar products. Acta Derm Venereol 1999: 79 (5): 390-391.
-
(1999)
Acta Derm Venereol
, vol.79
, Issue.5
, pp. 390-391
-
-
Franssen, M.E.1
Van Der Wilt, G.J.2
De Jong, P.C.3
Bos, R.P.4
Arnold, W.P.5
-
15
-
-
0032697030
-
Clinical pharmacokinetics and drug metabolism of tazarotene: A novel topical treatment for acne and psoriasis
-
Tang-Liu DD, Matsumoto RM, Usansky JI. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis. Clin Pharmacokinet 1999: 37 (4): 273-287.
-
(1999)
Clin Pharmacokinet
, vol.37
, Issue.4
, pp. 273-287
-
-
Tang-Liu, D.D.1
Matsumoto, R.M.2
Usansky, J.I.3
-
16
-
-
0033863408
-
Pharmacokinetics and safety of tazarotene
-
Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000: 43 (2 Pt 3): S31-S35.
-
(2000)
J Am Acad Dermatol
, vol.43
, Issue.2 PART 3
-
-
Menter, A.1
-
17
-
-
33748907250
-
Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques
-
Martín Ezquerra G, Sánchez Regaña M, Herrera Acosta E, Umbert Millet P. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol 2006: 5 (4): 334-336.
-
(2006)
J Drugs Dermatol
, vol.5
, Issue.4
, pp. 334-336
-
-
Martín Ezquerra, G.1
Sánchez Regaña, M.2
Herrera Acosta, E.3
Umbert Millet, P.4
-
18
-
-
0034722936
-
Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus
-
Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000: 70 (12): 1718-1721.
-
(2000)
Transplantation
, vol.70
, Issue.12
, pp. 1718-1721
-
-
Kainz, A.1
Harabacz, I.2
Cowlrick, I.S.3
Gadgil, S.D.4
Hagiwara, D.5
-
19
-
-
0141813542
-
Pregnancy after liver transplantation with tacrolimus immunosuppression: A single center's experience update at 13 years
-
Jain AB, Reyes J,Marcos A, et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003: 76 (5): 827-832.
-
(2003)
Transplantation
, vol.76
, Issue.5
, pp. 827-832
-
-
Jain, A.B.1
Reyes Jmarcos, A.2
-
20
-
-
25844507194
-
Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: A randomized, investigator-blind comparison
-
Draelos Z, Nayak A, Pariser D, et al. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. J Am Acad Dermatol 2005: 53 (4): 602-609.
-
(2005)
J Am Acad Dermatol
, vol.53
, Issue.4
, pp. 602-609
-
-
Draelos, Z.1
Nayak, A.2
Pariser, D.3
-
21
-
-
0031472297
-
The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis
-
Bourke JF, Mumford R, Whittaker P, et al. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J AmAcad Dermatol 1997: 37 (6): 929-934.
-
(1997)
J AmAcad Dermatol
, vol.37
, Issue.6
, pp. 929-934
-
-
Bourke, J.F.1
Mumford, R.2
Whittaker, P.3
-
22
-
-
2642696454
-
Reproductive and developmental toxicity studies of calcipotriol (MC903): (4) - A perinatal and postnatal study in rats by subcutaneous administration
-
Uchiyama H, Suzuki T, Koike Y, et al. Reproductive and developmental toxicity studies of calcipotriol (MC903): (4) - A perinatal and postnatal study in rats by subcutaneous administration. J Toxicol Sci 1996: 21 (Suppl. 2): 439-455.
-
(1996)
J Toxicol Sci
, vol.21
, Issue.SUPPL. 2
, pp. 439-455
-
-
Uchiyama, H.1
Suzuki, T.2
Koike, Y.3
-
23
-
-
3142521570
-
Reproductive and developmental toxicity studies of calcipotriol (MC903): (3) - A teratogenicity study in rabbits by subcutaneous administration
-
Uchiyama H, Suzuki T, Koike Y, et al. Reproductive and developmental toxicity studies of calcipotriol (MC903): (3) - A teratogenicity study in rabbits by subcutaneous administration. J Toxicol Sci 1996: 21 (Suppl. 2): 425-438.
-
(1996)
J Toxicol Sci
, vol.21
, Issue.SUPPL. 2
, pp. 425-438
-
-
Uchiyama, H.1
Suzuki, T.2
Koike, Y.3
-
25
-
-
33646828698
-
Occupational exposure to pesticides and pregnancy outcomes in gardeners and farmers: A study within the Danish National Birth Cohort
-
Zhu JL, Hjollund NH, Andersen AM, Olsen J. Occupational exposure to pesticides and pregnancy outcomes in gardeners and farmers: a study within the Danish National Birth Cohort. J Occup Environ Med 2006: 48: 347-352.
-
(2006)
J Occup Environ Med
, vol.48
, pp. 347-352
-
-
Zhu, J.L.1
Hjollund, N.H.2
Andersen, A.M.3
Olsen, J.4
-
26
-
-
84856008022
-
Narrowband UV-B phototherapy during pregnancy and folic acid depletion
-
Park KK, Murase JE.Narrowband UV-B phototherapy during pregnancy and folic acid depletion. Arch Dermatol 2012: 148 (1): 132-133.
-
(2012)
Arch Dermatol
, vol.148
, Issue.1
, pp. 132-133
-
-
Park, K.K.1
Murase, J.E.2
-
27
-
-
0025978777
-
Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis
-
Stern RS, Lange R. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol 1997: 127: 347-350.
-
(1997)
Arch Dermatol
, vol.127
, pp. 347-350
-
-
Stern, R.S.1
Lange, R.2
-
29
-
-
0032736894
-
The effects of methotrexate on pregnancy, fertility and lactation
-
Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA. The effects of methotrexate on pregnancy, fertility and lactation. QJM 1999: 92 (10): 551-563.
-
(1999)
QJM
, vol.92
, Issue.10
, pp. 551-563
-
-
Lloyd, M.E.1
Carr, M.2
McElhatton, P.3
Hall, G.M.4
Hughes, R.A.5
-
31
-
-
0027177186
-
Clinical teratology counseling and consultation repot: Low dose methotreaxate exposure in the early weeks of pregnancy
-
Feldkamp M, Carey JC. Clinical teratology counseling and consultation repot: low dose methotreaxate exposure in the early weeks of pregnancy. Teratology 1993: 47: 533-539.
-
(1993)
Teratology
, vol.47
, pp. 533-539
-
-
Feldkamp, M.1
Carey, J.C.2
-
32
-
-
0028217035
-
Methotrexate exposure prior and during pregnancy
-
Donnenfield AE. Methotrexate exposure prior and during pregnancy. Teratology 1994: 49: 79-81.
-
(1994)
Teratology
, vol.49
, pp. 79-81
-
-
Donnenfield, A.E.1
-
33
-
-
0025765366
-
Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children
-
Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991: 36: 243-248.
-
(1991)
Am J Hematol
, vol.36
, pp. 243-248
-
-
Aviles, A.1
Diaz-Maqueo, J.C.2
Talavera, A.3
Guzman, R.4
Garcia, E.L.5
-
34
-
-
0025315423
-
Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease
-
Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990: 88: 589-592.
-
(1990)
Am J Med
, vol.88
, pp. 589-592
-
-
Kozlowski, R.D.1
Steinbrunner, J.V.2
Mackenzie, A.H.3
Clough, J.D.4
Wilke, W.S.5
Segal, A.M.6
-
36
-
-
0005526050
-
Studies on the folic acid vitamins the persistence of amethopterin in mammalian tissues
-
Charache S, Condit PT, Humphreys SR. Studies on the folic acid vitamins 4: the persistence of amethopterin in mammalian tissues. Cancer 1960: 13 (2): 236-240.
-
(1960)
Cancer
, vol.13
, Issue.2
, pp. 236-240
-
-
Charache, S.1
Condit, P.T.2
Humphreys, S.R.3
-
37
-
-
0021176619
-
Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours
-
Rustin GJ, Booth M, Dent J, Salt S, Rustin F, Bagshawe KD. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. Br Med J 1984: 288: 103-106.
-
(1984)
Br Med J
, vol.288
, pp. 103-106
-
-
Rustin, G.J.1
Booth, M.2
Dent, J.3
Salt, S.4
Rustin, F.5
Bagshawe, K.D.6
-
39
-
-
0028107176
-
The transfer of drugs and other chemicals into human milk
-
Committee on drugs, American Academy of Pediatrics
-
Committee on drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 1994: 93: 137-150.
-
(1994)
Pediatrics
, vol.93
, pp. 137-150
-
-
-
40
-
-
0028275432
-
Teratogenic risk with etretinate and acitretin treatment
-
Geiger JM, Baudin M, Saurat JH. Teratogenic risk with etretinate and acitretin treatment. Dermatology 1994: 189 (2): 109-116.
-
(1994)
Dermatology
, vol.189
, Issue.2
, pp. 109-116
-
-
Geiger, J.M.1
Baudin, M.2
Saurat, J.H.3
-
41
-
-
0033044929
-
Potential risk of birth defects after acitretin discontinuation
-
Maradit H, Geiger JM. Potential risk of birth defects after acitretin discontinuation. Dermatology 1999: 198 (1): 3-4.
-
(1999)
Dermatology
, vol.198
, Issue.1
, pp. 3-4
-
-
Maradit, H.1
Geiger, J.M.2
-
42
-
-
0024538437
-
Overview of recent clinical pharmacokinetic studies with acitretin (Ro10-1670, etretin)
-
Brindley CJ. Overview of recent clinical pharmacokinetic studies with acitretin (Ro10-1670, etretin). Dermatologica 1989: 178: 79-87.
-
(1989)
Dermatologica
, vol.178
, pp. 79-87
-
-
Brindley, C.J.1
-
43
-
-
4243401636
-
Clinical evidence that acitretin is esterified to etretinate when administered with ethanol
-
Jensen BK, Chaws CL, Huselton CA. Clinical evidence that acitretin is esterified to etretinate when administered with ethanol. FASEB J 1992: 6: A1570.
-
(1992)
FASEB J
, vol.6
-
-
Jensen, B.K.1
Chaws, C.L.2
Huselton, C.A.3
-
44
-
-
0025130761
-
Acitretin excretion into human breast milk
-
Rollman O, Pihl-Lundin I. Acitretin excretion into human breast milk. Acta DermVenereol 1990: 70: 487-490.
-
(1990)
Acta DermVenereol
, vol.70
, pp. 487-490
-
-
Rollman, O.1
Pihl-Lundin, I.2
-
45
-
-
78649382560
-
The use of cyclosporine in dermatology: Part II
-
quiz 973-934
-
Ryan C, Amor KT, Menter A. The use of cyclosporine in dermatology: part II. J Am Acad Dermatol 2010: 63 (6): 949-972; quiz 973-934.
-
(2010)
J Am Acad Dermatol
, vol.63
, Issue.6
, pp. 949-972
-
-
Ryan, C.1
Amor, K.T.2
Menter, A.3
-
46
-
-
0028912568
-
Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients
-
Armenti VT, Ahlswede KM, Ahlswede BA, et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1995: 59: 476-479.
-
(1995)
Transplantation
, vol.59
, pp. 476-479
-
-
Armenti, V.T.1
Ahlswede, K.M.2
Ahlswede, B.A.3
-
47
-
-
0035041316
-
Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis
-
Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001: 71 (8): 1051-1055.
-
(2001)
Transplantation
, vol.71
, Issue.8
, pp. 1051-1055
-
-
Bar Oz, B.1
Hackman, R.2
Einarson, T.3
Koren, G.4
-
48
-
-
0031690689
-
Pregnancy outcomes in female renal transplant recipients
-
Armenti VT,McGrory CH, Cater JR, Radomski JS,Moritz MJ. Pregnancy outcomes in female renal transplant recipients. Transplant Proc 1998: 30 (5): 1732-1734.
-
(1998)
Transplant Proc
, vol.30
, Issue.5
, pp. 1732-1734
-
-
Armenti, V.T.1
McGrory, C.H.2
Cater, J.R.3
Radomski, J.S.4
Moritz, M.J.5
-
49
-
-
0030761217
-
Analysis of 629 pregnancy outcomes in renal transplant recipients with Sandimmune
-
Lamarque V, Leleu MF, Monka C, Krupp P. Analysis of 629 pregnancy outcomes in renal transplant recipients with Sandimmune. Transplant Proc 1997: 29: 2480.
-
(1997)
Transplant Proc
, vol.29
, pp. 2480
-
-
Lamarque, V.1
Leleu, M.F.2
Monka, C.3
Krupp, P.4
-
51
-
-
0032570250
-
Breast-feeding during treatment with cyclosporine
-
Nyberg G, Haljamäe U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation 1998: 65: 253-255.
-
(1998)
Transplantation
, vol.65
, pp. 253-255
-
-
Nyberg, G.1
Haljamäe, U.2
Frisenette-Fich, C.3
Wennergren, M.4
Kjellmer, I.5
-
52
-
-
0037938452
-
Antenatal steroid use is associated with increased gastroesophageal reflux in neonates
-
Chin SO, Brodsky NL, Bhandari V. Antenatal steroid use is associated with increased gastroesophageal reflux in neonates. Am J Perinatol 2003: 20 (4): 205-213.
-
(2003)
Am J Perinatol
, vol.20
, Issue.4
, pp. 205-213
-
-
Chin, S.O.1
Brodsky, N.L.2
Bhandari, V.3
-
53
-
-
34548833077
-
Long-term outcomes after repeat doses of antenatal corticosteroids
-
Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl JMed 2007: 357 (12): 1190-1198.
-
(2007)
N Engl JMed
, vol.357
, Issue.12
, pp. 1190-1198
-
-
Wapner, R.J.1
Sorokin, Y.2
Mele, L.3
-
54
-
-
0842263744
-
Pregnancy outcome after first trimester exposure to corticosteroids: A prospective controlled study
-
Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004: 18 (1): 93-101.
-
(2004)
Reprod Toxicol
, vol.18
, Issue.1
, pp. 93-101
-
-
Gur, C.1
Diav-Citrin, O.2
Shechtman, S.3
Arnon, J.4
Ornoy, A.5
-
55
-
-
0033662284
-
Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies
-
Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000: 62 (6): 385-392.
-
(2000)
Teratology
, vol.62
, Issue.6
, pp. 385-392
-
-
Park-Wyllie, L.1
Mazzotta, P.2
Pastuszak, A.3
-
56
-
-
84857116422
-
Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services
-
Hoeltzenbein M, Elefant E, Vial T, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 2012: 158A (3): 588-596.
-
(2012)
Am J Med Genet A
, vol.158 A
, Issue.3
, pp. 588-596
-
-
Hoeltzenbein, M.1
Elefant, E.2
Vial, T.3
-
57
-
-
84885218487
-
MYCOPHENOLATE MOFETIL - Mycophenolate mofetil tablet, film coated Ascend
-
LLC
-
MYCOPHENOLATE MOFETIL - mycophenolate mofetil tablet, film coated Ascend Laboratories, LLC. 2012.
-
(2012)
Laboratories
-
-
-
58
-
-
49649102679
-
Mycophenolate mofetil embryopathy may be dose and timing dependent
-
Ang GS, Simpson SA, Reddy AR. Mycophenolate mofetil embryopathy may be dose and timing dependent. Am J Med Genet A 2008: 146A (15): 1963-1966.
-
(2008)
Am J Med Genet A
, vol.146 A
, Issue.15
, pp. 1963-1966
-
-
Ang, G.S.1
Simpson, S.A.2
Reddy, A.R.3
-
59
-
-
78649232947
-
Safety of adalimumab in Crohn's disease during pregnancy: Case report and review of the literature
-
Jürgens M, Brand S, Filik L, et al. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature. Inflamm Bowel Dis 2010: 16 (10): 1634-1636.
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.10
, pp. 1634-1636
-
-
Jürgens, M.1
Brand, S.2
Filik, L.3
-
60
-
-
0026949254
-
The biosynthesis of tumor necrosis factor during pregnancy: Studies with a CAT reporter transgene and TNF inhibitors
-
Giroir BP, Peppel K, SilvaM, et al. The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors. Eur Cytokine Netw 1992: 3: 533-538.
-
(1992)
Eur Cytokine Netw
, vol.3
, pp. 533-538
-
-
Giroir, B.P.1
Peppel, K.2
Silva, M.3
-
61
-
-
34047178478
-
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy
-
Roux CH, Brocq O, Breuil V, et al. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 2007: 46: 695-698.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 695-698
-
-
Roux, C.H.1
Brocq, O.2
Breuil, V.3
-
62
-
-
33947249727
-
Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation
-
Skomsvoll JF, Wallenius M, Koksvik HS, et al. Drug insight: anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat Clin Pract Rheumatol 2007: 3: 156-164.
-
(2007)
Nat Clin Pract Rheumatol
, vol.3
, pp. 156-164
-
-
Skomsvoll, J.F.1
Wallenius, M.2
Koksvik, H.S.3
-
63
-
-
33646443354
-
Tumor necrosis factoralpha inhibition and VATER association: A causal relationship
-
Carter JD, Valeriano J, Vasey FB. Tumor necrosis factoralpha inhibition and VATER association: a causal relationship. J Rheumatol 2006: 33: 1014-1017.
-
(2006)
J Rheumatol
, vol.33
, pp. 1014-1017
-
-
Carter, J.D.1
Valeriano, J.2
Vasey, F.B.3
-
64
-
-
41849132893
-
Pregnancy outcome n women with psoriasis
-
Ben-David G, Sheiner E,Hallak M, et al. Pregnancy outcome n women with psoriasis. J Reprod Med 2008: 53: 183-187.
-
(2008)
J Reprod Med
, vol.53
, pp. 183-187
-
-
Ben-David, G.1
Sheiner Ehallak, M.2
-
65
-
-
58749115377
-
CRI (Club Rhumatismes et Inflammation) Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of literature
-
Berthelot JM, De Bandt M, Goupille P, et al. CRI (Club Rhumatismes et Inflammation). Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of literature. Joint Bone Spine 2009: 76: 28-34.
-
Joint Bone Spine 2009
, vol.76
, pp. 28-34
-
-
Berthelot, J.M.1
De Bandt, M.2
Goupille, P.3
-
66
-
-
78650170917
-
Conception and course of eight pregnancies in five women onTNF blocker etanercept treatment
-
Rump JA, Schonborn H. Conception and course of eight pregnancies in five women onTNF blocker etanercept treatment. Z Rheumatol 2010: 69: 903-909.
-
(2010)
Z Rheumatol
, vol.69
, pp. 903-909
-
-
Rump, J.A.1
Schonborn, H.2
-
68
-
-
16344369052
-
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
-
Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005: 21: 733-738.
-
(2005)
Aliment Pharmacol Ther
, vol.21
, pp. 733-738
-
-
Mahadevan, U.1
Kane, S.2
Sandborn, W.J.3
-
69
-
-
11144266570
-
Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis
-
Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004: 99: 2385-2392.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 2385-2392
-
-
Katz, J.A.1
Antoni, C.2
Keenan, G.F.3
Smith, D.E.4
Jacobs, S.J.5
Lichtenstein, G.R.6
-
70
-
-
80052805305
-
Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab
-
Heller MM, Wu JJ, Murase JE. Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab. J Am Acad Dermatol 2011: 65 (4): 870.
-
(2011)
J Am Acad Dermatol
, vol.65
, Issue.4
, pp. 870
-
-
Heller, M.M.1
Wu, J.J.2
Murase, J.E.3
-
72
-
-
67650992265
-
Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery
-
Kane S, Ford J, Cohen R,Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009: 43: 613-616.
-
(2009)
J Clin Gastroenterol
, vol.43
, pp. 613-616
-
-
Kane, S.1
Ford, J.2
Cohen Rwagner, C.3
-
73
-
-
70449706430
-
Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: Drug levels in maternal serum, cord blood, breast milk and the infant's serum
-
Murashima A,Watanabe N, Ozawa N, Saito H, Yamaguchi K. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis 2009: 68: 1793-1794.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1793-1794
-
-
Murashima, A.1
Watanabe, N.2
Ozawa, N.3
Saito, H.4
Yamaguchi, K.5
-
74
-
-
78650498507
-
Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation
-
Martin PL, Sachs C, Imai N, et al. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation. Birth Defects Res B Dev Reprod Toxicol 2010: 89 (5): 351-363.
-
(2010)
Birth Defects Res B Dev Reprod Toxicol
, vol.89
, Issue.5
, pp. 351-363
-
-
Martin, P.L.1
Sachs, C.2
Imai, N.3
-
75
-
-
84868629951
-
Treatment of severe psoriasis with ustekinumab during pregnancy
-
Andrulonis R, Ferris LK. Treatment of severe psoriasis with ustekinumab during pregnancy. J Drugs Dermatol 2012: 11 (10): 1240-1241.
-
(2012)
J Drugs Dermatol
, vol.11
, Issue.10
, pp. 1240-1241
-
-
Andrulonis, R.1
Ferris, L.K.2
|